Paper8092829
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
Berenguer J and 9 others. Antimicrob Agents Chemother, 1994. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma. Papers, record 8092829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8092829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Aspergillosis | Major topic |
| Cyclosporine | Major topic |
| Itraconazole | Major topic |
| Lung Diseases, Fungal | Major topic |
| Animals | |
| Drug Interactions | |
| Female | |
| Kidney | |
| Rabbits |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1310577 | Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis. | Am Rev Respir Dis | 1992 | https://conductscience.org/library/papers/1310577 | PubMed |
| 2 | 2066421 | 10 year review of invasive aspergillosis detected at necropsy. | J Clin Pathol | 1991 | https://conductscience.org/library/papers/2066421 | PubMed |
| 3 | 1317280 | Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis. | Chemotherapy | 1992 | https://conductscience.org/library/papers/1317280 | PubMed |
| 4 | 1605615 | Effect of cyclodextrin on the pharmacology of antifungal oral azoles. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1605615 | PubMed |
| 5 | 1326309 | Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment. | Eur J Cancer | 1992 | https://conductscience.org/library/papers/1326309 | PubMed |
| 6 | 1357148 | The pharmacokinetics of oral itraconazole in AIDS patients. | J Pharm Pharmacol | 1992 | https://conductscience.org/library/papers/1357148 | PubMed |
| 7 | 1186493 | Deep mycotic infection in the hospitalized adult: a study of 123 patients. | Medicine (Baltimore) | 1975 | https://conductscience.org/library/papers/1186493 | PubMed |
| 8 | 872495 | Response optimization of drug dosage: antiarrhythmic studies with tocainide. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/872495 | PubMed |
| 9 | 6340275 | Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. | Transplantation | 1983 | https://conductscience.org/library/papers/6340275 | PubMed |
| 10 | 6660859 | Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6660859 | PubMed |
| 11 | 2992106 | Itraconazole treatment of murine aspergillosis. | Sabouraudia | 1985 | https://conductscience.org/library/papers/2992106 | PubMed |
| 12 | 3027843 | Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. | Rev Infect Dis | 1987 | https://conductscience.org/library/papers/3027843 | PubMed |
| 13 | 3027853 | Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. | Rev Infect Dis | 1987 | https://conductscience.org/library/papers/3027853 | PubMed |
| 14 | 2886752 | Interaction of cyclosporin and itraconazole. | Lancet | 1987 | https://conductscience.org/library/papers/2886752 | PubMed |
| 15 | 2889119 | Itraconazole and cyclosporin nephrotoxicity. | Lancet | 1987 | https://conductscience.org/library/papers/2889119 | PubMed |
| 16 | 3681380 | Favorable outcome of invasive aspergillosis in patients with acute leukemia. | J Clin Oncol | 1987 | https://conductscience.org/library/papers/3681380 | PubMed |
| 17 | 2890938 | Time course of cyclosporin/itraconazole interaction. | Lancet | 1987 | https://conductscience.org/library/papers/2890938 | PubMed |
| 18 | 2543220 | Treatment of invasive aspergillosis with itraconazole. | Am J Med | 1989 | https://conductscience.org/library/papers/2543220 | PubMed |
| 19 | 2540949 | Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. | Drugs | 1989 | https://conductscience.org/library/papers/2540949 | PubMed |
| 20 | 3184859 | Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. | Lab Anim Sci | 1988 | https://conductscience.org/library/papers/3184859 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41484391 | Pathologic evaluation of Syzygium aromaticum essential oil against pulmonary aspergillosis in non-neutropenic immunosuppressed rabbits. | Sci Rep | 2026 | https://conductscience.org/library/papers/41484391 | PubMed |
| 38175242 | Aspergillus fumigatus escape mechanisms from its harsh survival environments. | Appl Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/38175242 | PubMed |
| 33007839 | Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets? | J Fungi (Basel) | 2020 | https://conductscience.org/library/papers/33007839 | PubMed |
| 32201545 | Extrapolating Antifungal Animal Data to Humans - Is it reliable? | Curr Fungal Infect Rep | 2020 | https://conductscience.org/library/papers/32201545 | PubMed |
| 25587296 | Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective. | Can J Infect Dis Med Microbiol | 2014 | https://conductscience.org/library/papers/25587296 | PubMed |
| 24595533 | Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/24595533 | PubMed |
| 23351398 | Preparation and evaluation of inhalable itraconazole chitosan based polymeric micelles. | Daru | 2012 | https://conductscience.org/library/papers/23351398 | PubMed |
| 22644590 | New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis. | Pharm Res | 2012 | https://conductscience.org/library/papers/22644590 | PubMed |
| 19857383 | What is the role of therapeutic drug monitoring in antifungal therapy? | Curr Infect Dis Rep | 2009 | https://conductscience.org/library/papers/19857383 | PubMed |
| 18955533 | Antifungal therapeutic drug monitoring: established and emerging indications. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/18955533 | PubMed |
| 17589527 | Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. | Bone Marrow Transplant | 2007 | https://conductscience.org/library/papers/17589527 | PubMed |
| 15015031 | Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. | Eur J Clin Microbiol Infect Dis | 2004 | https://conductscience.org/library/papers/15015031 | PubMed |
| 12202554 | Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study. | J Clin Microbiol | 2002 | https://conductscience.org/library/papers/12202554 | PubMed |
| 11585779 | Antifungal susceptibility testing: practical aspects and current challenges. | Clin Microbiol Rev | 2001 | https://conductscience.org/library/papers/11585779 | PubMed |
| 11181372 | Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11181372 | PubMed |
| 10639380 | In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10639380 | PubMed |
| 9884817 | Optimisation of itraconazole therapy using target drug concentrations. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9884817 | PubMed |
| 7793887 | Potential use of a simplified method for determination of itraconazole levels in plasma and esophageal tissue by using high-performance liquid chromatography. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7793887 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8092829
GET https://conductscience.org/api/papers/v1/8092829/references?page=2